Mobil uyumlu tasarımı sayesinde her yerden erişim imkanı sunan bettilt her zaman yanınızda.
Gelişmiş arayüzüyle bettilt versiyonu bahisçiler için beklentileri yükseltiyor.
Adres değişikliklerini takip eden kullanıcılar bettilt sayesinde kesintisiz erişim sağlıyor.
Basketbol tutkunları için en iyi kupon fırsatları bettilt sayfasında yer alıyor.
CyPath® Lung illuminates the lung microenvironment using flow cytometry+AI to identify cell populations that change when cancer is present. Our noninvasive diagnostic test detects lung cancer as early as its curative Stage 1A.
EARLY DETECTION: Proven to detect cancer at Stage 1A, when treatment is most effective.
EASE OF USE: No surgery, no radiation exposure — just a simple kit for at-home sample collection.
ACTIONABLE RESULTS: Physicians receive a definitive answer as well as probability score to define next steps in care.
IN INDIVIDUALS AT HIGH RISK WITH PULMONARY NODULES LESS THAN 20 MILLIMETERS*
*M. Lemieux, et al., Detection of early-stage cancer in sputum using automated flow cytometry and machine learning, Respiratory Research, Jan 2023. Nodules detected by low-dose computed tomography. Test performance reflects 95% Area Under the Curve; 95% Confidence Interval; 99% Negative Predictive Value, 44% Positive Predictive Value. This test is a Laboratory Developed Test.
Precision Pathology Laboratory Services (PPLS), a bioAffinity Technologies company, provides high-quality pathology solutions for physicians in outpatient settings. Our CAP-accredited and CLIA-certified laboratory is staffed by experienced pathologists and technical experts committed to accuracy, reliability, and scientific integrity.
Contact Us
(210) 698-5334
info@bioaffinitytech.com
3300 Nacogdoches Road, Suite 216
San Antonio, TX 78217